Our Research

Despite major advances in biomedical science, effective treatment of complex diseases such as cancer, neurodegenerative disorders, and chronic inflammatory conditions remains limited by the inability of traditional  therapies to overcome biological barriers, achieve precise targeting, and minimize off-target effects. Conventional therapies and drug delivery systems often lack specificity, leading to suboptimal therapeutic outcomes, systemic toxicity, and reduced patient quality of life. The Fetse Lab addresses these challenges through an integrated research program focused on peptide-based modulation of protein–protein interactions, targeted drug and gene delivery systems, and biomaterial platforms for minimally invasive or non-invasive therapies.